Scilex Holding Company faces Nasdaq non-compliance for missing Q3 2024 financial report deadline.

Scilex Holding Company, a California firm focused on non-opioid pain treatments, received a notice from Nasdaq for not filing its Q3 2024 financial report, leading to non-compliance with listing rules. The company has until January 20, 2025, to submit a plan for regaining compliance, with a possible extension to July 20, 2025, if the plan is accepted. Scilex intends to file the report as soon as possible.

November 22, 2024
4 Articles

Further Reading